Talk:Multidisciplinary Association for Psychedelic Studies

completely new introductory section
In adding this section, I've removed a couple of quotes about MAPS' relationship with NIDA and the DEA. I'm planning on putting these back in when I add a more complete section on MAPS' DEA lawsuit, and all of the research mentioned is mentioned again with [citation needed] marks in the "Achievements" section. I'll be going through and adding those citations soon as I develop the page around the new contents list mentioned below.

Kymerikal (talk) 16:14, 20 February 2010 (UTC)

proposed new contents list for new MAPS wiki page
I'm working on getting this page fully rewritten. It could use a lot more detail, clearer organization, and of course sourcing, about MAPS-sponsored research studies, for example. Here's the contents list that I'm working with as I compose a draft. I was going to just throw it all up there as I got them done, but since it looks like there's a couple of people watching this article I thought it might be more productive to ask for comments?

''1 MAPS 1.1 Overview 1.2 Mission statement

2 Organization 2.1 Non-profit status 2.2 Membership structure 2.3 Board of directors

3 History 3.1 Founding 3.2 1986-1996 3.3 1997-2004 3.4 2005-present

4 Research 4.1 MDMA 4.2 Medical marijuana 4.3 Psilocybin 4.4 LSD 4.5 Ibogaine

5 Legal 5.1 Medical marijuana DEA lawsuit

6 Education 6.1 Conferences 6.2 Seminars 6.3 Community events

7 Media and publishing

8 See also 9 References 10 External links ''

Kymerikal (talk) 16:23, 18 February 2010 (UTC)

relationship with NIDA
I've removed part of a sentence regarding MAPS' relationship with the NIDA. The phrase was attributed to MAPS founder Rick Doblin regarding the NIDA and read:

"and "we don't want their weed" anyways becasue it is "schwag" a street term for low grade cheap pot."

This was based on an actual quote by Doblin in which he said "we don't want their (the NIDA's) weed." Doblin was comparing the quality of NIDA medical marijuana to that made by Paget, GW Pharmaceuticals for research purposes. The quote was taken out of context such that it might imply that Doblin was discussing NIDA marijuana for personal use. Further, Doblin did not use the term "schwag" - that term was used by the author of the Mother Jones article. Jts3k 22:03, 23 April 2007 (UTC)
 * Nevertheless, it's a matter of historical record that Government cannabis is basically worthless. Viriditas (talk) 00:18, 15 January 2009 (UTC)


 * Is the neutrality tag still needed? Anyone? Sud Ram (talk) 08:39, 17 February 2010 (UTC)

Multiple stubs
Grutness tells me that an article should be in no more than two stub categories, so i'm going to eliminate the "organization" stub as it seems the least useful of the three. if there are objections drop me a note and we can work something else out. --Heah (talk) 19:06, 21 May 2005 (UTC)

Medical Marijuana Monopoly
This section requires an update, as it references 2006 as its most recent date. Further, most content appears to be identical to information on the NIDA page, where it has the citations that are missing from the MAPS page. — Preceding unsigned comment added by Gnosotros (talk • contribs) 22:58, 14 April 2011 (UTC)

Vastly out of date, please update, move things to history, and focus on current activities
I am too close to the subject to edit the page, but I can see that the bulk of the article seems to have been written in about 2012 and never updated since. The organization has changed radically since then, focusing on MDMA research toward PTSD and not continuing most other substance research. Finances are dramatically different, and it now owns a roughly 100-person subsidiary that will be commercializing MDMA after FDA approval, expected in 2024. It's fun to see a capsule view of the org from a decade ago, but Wikipedia readers deserve better. There should be no trouble finding modern, independent coverage of MAPS to cite, as their issue is heading rapidly toward the mainstream. --Gnuish (talk) 08:15, 22 July 2023 (UTC)


 * Agreed. I just put up a notice for this. I've been working on revamping Bluelight's page and will start with MAPS afterwards. BromoPhenethylamine (talk) 05:10, 5 February 2024 (UTC)